IMI-Care

Covid-19 Research Consortium

The EU IMI-Care Project

SCIFEON chosen as the Scientific Data Management Platform for the largest EU Covid-19 research project

Danish software startup SCIFEON will help researchers at the World’s largest pharmaceutical companies and Europe’s leading universities to develop a treatment for the Corona virus.

SCIFEON participates in the IMI-CARE (Innovative Medicines Initiative, Corona Accelerated Research) project. The initiative is invested in equal amounts from The European Commission and the pharmaceutical industry.

The budget is €72 million euros and the goal is to provide both a treatment for the current and possibly future corona viruses. – I am happy, proud and excited! We are now in the process of organizing the data-sharing between more than 30 project partners, says Thomas P. Boesen.

SCIFEON consists of a database with an intuitive user interface, where researchers can build up elements they know from their laboratories, thus avoiding the tedious use of paper and spreadsheets, intended for a rigorous accounting world that is far from the researchers’ unpredictable everyday life.

Flexibility is the foundation of our system, which is built by researchers for researchers, explains Thomas P. Boesen.

Ready to take your labs to the next level?

Comments are closed.